Danaher Corp.
Income Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Revenue | $10.52B | $12.70B | $11.03B |
| Biotechnology | — | — | — |
| Life Sciences | — | — | — |
| Diagnostics | — | — | — |
| Dental | — | — | — |
| Environmental & Applied Solutions | — | — | — |
| Cost of Revenue | $5.45B | $6.76B | $5.99B |
| Gross Profit | $5.07B | $5.94B | $5.04B |
| Gross Margin | 48.2% | 46.8% | 45.7% |
| Operating Expenses | |||
| Research & Development | $600.3M | $725.4M | $601.4M |
| SG&A Expense | $3.12B | $3.35B | $2.71B |
| Operating Income | $1.44B | $1.87B | $1.74B |
| Operating Margin | 13.7% | 14.7% | 15.8% |
| Interest Expense | $118.7M | $130.2M | $109.7M |
| Pretax Income | $1.33B | $1.75B | $1.64B |
| Income Tax Expense | $239.0M | $431.7M | $423.1M |
| Net Income | $1.15B | $1.32B | $1.37B |
| Net Margin | 11.0% | 10.4% | 12.4% |
| EPS (Basic) | $1.80 | $2.06 | $2.20 |
| EPS (Diluted) | $1.73 | $1.98 | $2.10 |
| Shares Outstanding (Basic) | 641.5M | 638.7M | 622.5M |
| Shares Outstanding (Diluted) | 671.5M | 671.7M | 658.9M |
| Dividends Per Share | — | — | — |